cbdMD, Inc. (NYSE American: YCBD) announced its first‑quarter fiscal 2026 results on February 17, 2026, reporting a 12% sequential increase in revenue and a strengthening of liquidity as the company continues to stabilize its core business.
The company highlighted that the acquisition of Bluebird Botanicals has begun to deliver early benefits, with the integration expected to unlock additional revenue streams and cost synergies in the second quarter of the fiscal year.
Management noted that the company’s capital structure reset and debt‑free status have positioned YCBD to pursue profitable growth, while the improved cash position supports ongoing investment in product development and market expansion.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.